Table 2.

Cross sectional adjusted relative prevalence for non-alcoholic fatty liver disease by quintiles of baseline NT-proBNP in non-diabetic individuals without self-reported liver disease.

		Quintiles of NT-proBNP, pg/mL
	(rang e)	(4.9 - 19.2)	(19.3 - 40.9)	(41.0 - 70.9)	(71.0 - 135.2)	(135.5 - 3460)
NAF LD	n	888	902	929	919	891	Linear trend	p value
< 40 HU	Mode l 1	1	0.63 (0.44 - 0.89)	0.70 (0.49 - 1.01)	0.67 (0.46 - 0.99)	0.40 (0.24 - 0.68)	0.81 (0.72 - 0.92)	0.001
	Mode l 2	1	0.64 (0.41 - 1.00)	0.78 (0.51 - 1.21)	0.72 (0.45 - 1.15)	0.48 (0.26 - 0.88)	0.82 (0.71 - 0.96)	0.01
	Mode l 3	1	0.66 (0.43 - 1.02)	0.78 (0.51 - 1.2)	0.74 (0.47 - 1.18)	0.54 (0.29 - 1.00)	0.88 (0.76 - 1.01)	0.07
< 1	Mode l 1	1	0.77 (0.61 - 0.98)	0.81 (0.63 - 1.03)	0.58 (0.44 - 0.77)	0.46 (0.33 - 0.63)	0.82 (0.75 - 0.89)	<0.00 01
	Mode l 2	1	0.83 (0.62 - 1.12)	0.86 (0.63 - 1.17)	0.6 (0.42 - 0.85)	0.49 (0.33 - 0.74)	0.87 (0.78 - 0.97)	0.001
	Mode l 3	1	0.87 (0.65 - 1.15)	0.86 (0.64 - 1.16)	0.63 (0.45 - 0.89)	0.54 (0.37 - 0.81)	0.87 (0.78 - 0.97)	0.01

HU = Hounsfield units. Relative risk adjusted by model 1 = age, race, sex. Model 2 = model 1 + percent of dietary calories derived from fat, total intentional exercise, alcoholic drinks per week and interleukin-6. Model 3 = model 2 + metabolic syndrome. NAFLD = non-alcohol fatty liver disease defined as an average liver attenuation coefficient < 40 HU or a liver to spleen ration < 1. Linear trend is per unit of log (NT-proBNP).